Gary Lyons

(Mr. Gary Lyons)

Currently holds positions in Brickell Biotech Inc, Retrophin Inc, Rigel Pharmaceuticals Inc and Neurocrine Biosciences Inc

Positions

Position Company Period
Director Brickell Biotech Inc Aug. 31, 2019 -
Independent Chairman of the Board Retrophin Inc May 18, 2016 -
Independent Director Rigel Pharmaceuticals Inc Oct. 6, 2005 -
Independent Director Neurocrine Biosciences Inc Jan. 14, 2008 -
Independent Director Brickell Biotech Inc March 1, 1997 - Aug. 31, 2019
Independent Director Plus Therapeutics Inc Oct. 7, 2013 - Jan. 30, 2019
Independent Director Retrophin Inc Oct. 9, 2014 - May 18, 2016
Independent Director Humanigen Inc Jan. 1, 2011 - Nov. 19, 2015
Director Poniard Pharmaceuticals Inc July 9, 2009 - Jan. 3, 2012
Gary Lyons's trades of Brickell Biotech Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-10-04 2024-10-04 PS Planned sale
18,821 -27.0%
15.15
USD 285,227
18,821 -27.0% 15.15 USD 285,227
2024-10-04 2024-10-04 PS Planned sale
21,179 -23.3%
14.35
USD 303,874
21,179 -23.3% 14.35 USD 303,874
2024-08-15 2024-08-13 PS Planned sale
11,570 -8.9%
150.43
USD 1,740,450
11,570 -8.9% 150.43 USD 1,740,450
2024-07-18 2024-07-16 PS Planned sale
930 -0.8%
150.03
USD 139,530
930 -0.8% 150.03 USD 139,530
2024-05-16 2024-05-14 PS Planned sale
12,500 -9.7%
135.63
USD 1,695,370
12,500 -9.7% 135.63 USD 1,695,370
2023-12-27 2023-12-22 PS Planned sale
10,000 -4.9%
130.04
USD 1,300,443
10,000 -4.9% 130.04 USD 1,300,443
2023-12-05 2023-12-01 PS Planned sale
5,000 -2.4%
116.77
USD 583,837
5,000 -2.4% 116.77 USD 583,837
2023-09-14 2023-09-12 PS Planned sale
5,000 -2.4%
115.02
USD 575,120
5,000 -2.4% 115.02 USD 575,120
2023-09-06 2023-09-01 PS Planned sale
5,000 -2.4%
110.06
USD 550,316
5,000 -2.4% 110.06 USD 550,316
2022-11-02 2022-10-31 PS Planned sale
15,000 -6.9%
114.76
USD 1,721,403
15,000 -6.9% 114.76 USD 1,721,403
2022-10-05 2022-10-04 PS Planned sale
5,000 -2.4%
110.54
USD 552,711
5,000 -2.4% 110.54 USD 552,711
2022-04-27 2022-04-25 PS Planned sale
15,000 -6.7%
92.76
USD 1,391,393
15,000 -6.7% 92.76 USD 1,391,393
2021-10-12 2021-10-07 PS Planned sale
5,000 -2.3%
105.06
USD 525,294
5,000 -2.3% 105.06 USD 525,294
2021-06-14 2021-06-10 PS Planned sale
10,000 -4.5%
100.27
USD 1,002,743
10,000 -4.5% 100.27 USD 1,002,743
2021-01-27 2021-01-26 PS Planned sale
400 -0.2%
120.00
USD 48,000
400 -0.2% 120.00 USD 48,000
2021-01-27 2021-01-25 PS Planned sale
1,600 -0.7%
120.03
USD 192,047
1,600 -0.7% 120.03 USD 192,047
2019-11-05 2019-11-01 PS Planned sale
5,000 -2.1%
100.22
USD 501,104
5,000 -2.1% 100.22 USD 501,104
2019-07-31 2019-07-30 PS Planned sale
10,000 -4.1%
92.07
USD 920,686
10,000 -4.1% 92.07 USD 920,686
2016-12-07 2016-12-05 S Sale
7,078 -47.5%
2.30
USD 16,248
7,078 -47.5% 2.30 USD 16,248
2013-05-28 2013-05-23 B Purchase
5,953 +10.4%
0.01
USD 60
5,953 +10.4% 0.01 USD 60
2011-05-31 2011-05-26 B Purchase
18,750 +60.0%
0.01
USD 188
18,750 +60.0% 0.01 USD 188
2010-05-27 2010-05-25 B Purchase
18,750 +150.0%
0.01
USD 188
18,750 +150.0% 0.01 USD 188
2004-07-02 2004-07-01 PS Planned sale
2,500 -0.4%
51.00
USD 127,500
2,500 -0.4% 51.00 USD 127,500
2004-07-02 2004-07-01 PS Planned sale
1,250 -0.2%
51.08
USD 63,851
1,250 -0.2% 51.08 USD 63,851
2004-07-02 2004-07-01 PS Planned sale
1,250 -0.2%
51.35
USD 64,188
1,250 -0.2% 51.35 USD 64,188
2004-07-02 2004-07-01 PS Planned sale
5,000 -0.8%
51.75
USD 258,750
5,000 -0.8% 51.75 USD 258,750
2004-05-05 2004-05-03 PS Planned sale
5,000 -0.8%
62.75
USD 313,750
5,000 -0.8% 62.75 USD 313,750
2004-05-05 2004-05-03 PS Planned sale
5,000 -0.8%
62.50
USD 312,500
5,000 -0.8% 62.50 USD 312,500
// ... existing code ... // ... rest of the file ...